Singapore Sepsis Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, Blood Culture Media, Assay Kits & Reagents, Software, and Others), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, and Others), By Testing Type (Laboratory Testing and PoC Testing), By Diagnostic Method (Automated Diagnostics and Conventional Diagnostics), and Singapore Sepsis Diagnostics Market Insights, Industry Trend, Forecasts to 2035

Singapore Sepsis Diagnostics Market Insights Forecasts to 2035

• The Singapore Sepsis Diagnostics Market Size Was Estimated at USD 15.93 Million in 2024
• The Singapore Sepsis Diagnostics Market Size is Expected to Grow at a CAGR of Around 12.01% from 2025 to 2035
• The Singapore Sepsis Diagnostics Market Size is Expected to Reach USD 55.45 Million by 2035

According to a research report published by Spherical Insights & Consulting, The Singapore Sepsis Diagnostics Market size is anticipated to reach USD 55.45 Million by 2035, Growing at a CAGR of 12.01% from 2025 to 2035. The Singapore sepsis diagnostics market is driven by the rising prevalence of sepsis and infectious diseases, an aging population with weakened immunity, increasing hospitalizations and ICU admissions, growing demand for rapid and accurate diagnostic tests, and advancements in molecular diagnostics and point-of-care testing. Government initiatives to improve healthcare infrastructure and infection management further support market growth.

Market Overview

The Singapore sepsis diagnostics market represents the industry that concentrates on the creation, manufacture, sale, and application of diagnostic tools and tests for identifying sepsis, a severe body reaction to infection, in Singapore. This market covers blood culture tests, molecular diagnostics, biomarkers, point-of-care testing devices, and sophisticated laboratory assays that are used in hospitals, clinics, and diagnostic laboratories. It is meant to help the early detection of the disease, the prompt treatment of the patients, and better patient outcomes, and is influenced by factors like healthcare demand, technological advancements, and government-supported infection control programs.

Singapore's adoption of the sepsis diagnostics market is attributed to the growing population health needs and the increasing incidence of severe infections. The nation with a population of approximately 5.9 million is witnessing an increasing sepsis problem, particularly among the elderly population, which is expected to comprise 25% of those aged 65 and above by 2030. Cases of sepsis annually lead to hospitalizations, intensive care unit admissions, and high mortality, thus calling for early identification and quick diagnosis. The existence of chronic diseases, post-surgical infections, and immunocompromised patients is one of the factors that has escalated the need for advanced molecular diagnostics, point-of-care tests, and biomarker-based solutions for patient outcome improvement and healthcare cost reduction.

The government actively backs this market with innovation, driven healthcare policies, and funding programs. According to the RIE 2025 roadmap, more than SGD 25 billion will be spent on healthcare research, particularly in the area of diagnostics innovation. Institutions such as Enterprise Singapore and the Economic Development Board (EDB) offer funding, grants, and incentives to help speed up R&D in molecular diagnostics, rapid testing, and biomarker development. These efforts facilitate the creation and usage of top-notch, locally relevant diagnostic tools, thus making the Singapore sepsis diagnostics market a strategically healthy market for public health readiness, clinical efficiency, medical innovation, and investment opportunities.

Report Coverage

This research report categorizes the market for the Singapore sepsis diagnostics market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Singapore sepsis diagnostics market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Singapore sepsis diagnostics market.

Driving Factors

The Singapore sepsis diagnostics market continues to be driven by factors such as the increasing prevalence of sepsis, the aging population, and the rise in hospitalizations and surgeries. The expansion is backed by innovations in molecular diagnostics and point-of-care testing, government schemes such as RIE 2025, and the emphasis on early detection for better patient outcomes.

Restraining Factors

The Singapore sepsis diagnostics market is restrained by factors like the high price of advanced diagnostic tests, limited awareness and usage in smaller clinics, difficult regulatory compliance, and competition from well-known laboratory-based diagnostics. Furthermore, the absence of trained staff and financial limitations in some healthcare institutions may also hinder the market's widespread adoption.

Market Segmentation

The Singapore sepsis diagnostics market share is classified into product, technology, testing type, and diagnostic method.

• The blood culture media segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Singapore sepsis diagnostics market is segmented by product into instruments, blood culture media, assay kits & reagents, software, and others. Among these, the blood culture media segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The blood culture media segment is growing because it is essential for the rapid and accurate detection of pathogens in sepsis cases, widely used in hospitals and diagnostic laboratories, and critical for early diagnosis and timely treatment, which helps reduce sepsis-related mortality and healthcare costs. Increasing awareness of sepsis management protocols further drives demand for blood culture media in Singapore.

• The microbiology segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

The Singapore sepsis diagnostics market is segmented by technology into microbiology, molecular diagnostics, immunoassays, flow cytometry, and others. Among these, the microbiology segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The microbiology segment is growing because it forms the standard method for detecting sepsis-causing pathogens through blood cultures and microbial analysis, widely used in hospitals and diagnostic laboratories. Its reliability, cost-effectiveness, and role in guiding targeted antibiotic therapy drive strong demand in Singapore’s healthcare system.

• The laboratory testing segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Singapore sepsis diagnostics market is segmented by testing type into laboratory testing and PoC testing. Among these, the laboratory testing segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The laboratory testing media segment is growing because it provides highly accurate and comprehensive analysis for sepsis diagnosis, is widely used in hospitals and clinical laboratories, and supports early detection, pathogen identification, and treatment guidance, which are critical for reducing sepsis-related mortality in Singapore.

• The automated diagnostics segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Singapore sepsis diagnostics market is segmented by diagnostic method into automated diagnostics and conventional diagnostics. Among these, the automated diagnostics segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The automated diagnostics media segment is growing because it offers faster, more accurate, and higher-throughput sepsis testing compared to conventional methods. Its adoption in hospitals and laboratories helps reduce diagnosis time, improve patient outcomes, and streamline workflow, driving strong demand in Singapore.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Singapore sepsis diagnostics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Innoquest Diagnostics Pte. Ltd.
• Singapore Diagnostics
• Parkway Laboratories
• QIAGEN Singapore Pte. Ltd.
• bioMérieux ASEAN Clinical
• Thermo Fisher Scientific Inc.
• Roche Diagnostics
• Becton, Dickinson and Company (BD)
• Luminex Corporation
• Danaher Corporation
• Seegene Inc.
• Acumen Diagnostics
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Singapore, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Singapore sepsis diagnostics market based on the below-mentioned segments:

Singapore Sepsis Diagnostics Market, By Product

• Instruments
• Blood Culture Media
• Assay Kits & Reagents
• Software
• Others

Singapore Sepsis Diagnostics Market, By Technology

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Others

Singapore Sepsis Diagnostics Market, By Testing Type

• Laboratory Testing
• PoC Testing

Singapore Sepsis Diagnostics Market, By Diagnostic Method

• Automated Diagnostics
• Conventional Diagnostics